IDEAYA BIOSCIENCES INC (IDYA:NASDAQ)

$40.11 -1.66 (-3.9741%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 71

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed IDEAYA BIOSCIENCES INC (IDYA:NASDAQ) News Sources

The Bull Case For IDEAYA Biosciences (IDYA) Could Change Following Wider Loss And New Roche Partnership

05-08-2026

yahoo.com

IDEAYA Biosciences and Servier Provide Complete Data from Phase 2/3 Registrational OptimUM-02 Trial of the Darovasertib Combination in First Line HLA*A2:01 Negative Metastatic Uveal Melanoma in a Late-Breaking Oral Presentation at ASCO

01-06-2026

yahoo.com

IDEAYA Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

08-06-2026

yahoo.com

IDEAYA Announces Pricing of $300 Million Offering of Common Stock and Pre-Funded Warrants

09-06-2026

yahoo.com

IDEAYA Biosciences Announces IDE892, a Potential Best-in-Class MTA-Cooperative PRMT5 Inhibitor, Initiates a Phase 1/2 Clinical Combination Study in MTAP-Deleted Pancreatic and Lung Cancers

15-06-2026

yahoo.com

IDEAYA Biosciences Announces Yujiro S. Hata Elected Chairman of its Board of Directors

17-06-2026

yahoo.com

IDEAYA Biosciences Announces ESMO 2026 Presentations for Darovasertib and IDE849 Clinical Programs

17-07-2026

yahoo.com

IDEAYA Biosciences Announces IDE892, a Potential Best-in-Class MTA-Cooperative PRMT5 Inhibitor, Initiates Part 2 Monotherapy Expansion in the Phase 1/2 Study in MTAP-Deleted Pancreatic and Lung Cancers

27-07-2026

yahoo.com

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

31-07-2026

yahoo.com

IDEAYA Biosciences Announces Clinical Collaboration with Genentech in MTAP-Deleted KRAS G12D-Mutant Pancreatic Cancer

19-08-2026

yahoo.com

IDEAYA BIOSCIENCES INC (IDYA:NASDAQ) Sentiment Trend

0 25 50 75 100 87 66 60 69 64 74 79 64 68 78 05-08-2026 01-06-2026 08-06-2026 09-06-2026 15-06-2026 17-06-2026 17-07-2026 27-07-2026 31-07-2026 19-08-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

IDEAYA BIOSCIENCES INC (IDYA:NASDAQ) FAQs

toggle

What is the current price of IDEAYA BIOSCIENCES INC (IDYA:NASDAQ)?

The current price of IDEAYA BIOSCIENCES INC (IDYA:NASDAQ) is $40.11.


toggle

IDEAYA BIOSCIENCES INC (IDYA:NASDAQ) absolute price change since previous trading day?

The absolute price change of IDEAYA BIOSCIENCES INC (IDYA:NASDAQ) since the previous trading day is $-1.66.


toggle

IDEAYA BIOSCIENCES INC (IDYA:NASDAQ) percentage price change since previous trading day?

The percentage price change of IDEAYA BIOSCIENCES INC (IDYA:NASDAQ) since the previous trading day is -3.9741%.


toggle

What is the most recent average sentiment score for IDEAYA BIOSCIENCES INC (IDYA:NASDAQ)?

The most recent average sentiment score for IDEAYA BIOSCIENCES INC (IDYA:NASDAQ) is 71 out of 100.


toggle

What is the most recent average sentiment for IDEAYA BIOSCIENCES INC (IDYA:NASDAQ)?

The most recent sentiment for IDEAYA BIOSCIENCES INC (IDYA:NASDAQ) is .


SEC-8K** Filing Available For IDEAYA BIOSCIENCES INC (IDYA:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.